In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Nichi-Iko launches tender offer for Sagent Pharmaceuticals for $735mm; 85.6% of shares successfully tendered

Executive Summary

Japanese pharma Nichi-Iko Pharmaceutical Co. Ltd. launched a $735mm in cash tender offer for generics company Sagent Pharmaceuticals Inc. The tender will commence in 15 business days (and remain open for a minimum of 20 days thereafter) followed by a second-step merger.
Deal Industry
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Contract
    • Payment Includes Cash
    • Full Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register